() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: R&D

Westleaf Enters Exclusive Partnership with Industry Leader in Cannabis Derivative Product Research and Production

Westleaf Inc. (TSX-V: WL) ("Westleaf"), is pleased to announce it has executed a term sheet with Xabis Inc. ("Xabis"), whereby Xabis has agreed, subject to execution of a definitive agreement, to provide expertise to the Company's Calgary cannabis extraction and production facility. The facility formerly known as Delta West, will be rebranded The Plant by Westleaf Labs ("The Plant") after Westleaf consolidated its interest in The Plant to 100%. Provided Health Canada issues the applicable license for The Plant, the extraction and production facility under construction in south east Calgary is expected to produce cannabis derivative products and, after legalization of such products which is expected later this year, consumables, topicals and other cannabis infused products, subject to and in compliance with provincial and federal regulations.
Read more

THC purchases an additional lot in its current Kelowna location

VANCOUVER, Oct. 16, 2018 /CNW/ - THC BioMed Intl Ltd. ("THC" or the "Company") (CSE: THC) announces that it has purchased an additional strata lot in the industrial complex in Kelowna it currently occupies and where additional lots were recently purchased on June 29, 2018.  The additional lot will be used for production purposes. THC purchased this property as part of its expansion plan due to high demand for its products.
Read more